Stereotactic Body Radiotherapy vs Sorafenib Alone in Hepatocellular Carcinoma: The NRG Oncology/RTOG 1112 Phase 3 Randomized Clinical Trial.
Dawson LA, Winter KA, Knox JJ, Zhu AX, Krishnan S, Guha C, Kachnic LA, Gillin MT, Hong TS, Craig TD, Williams TM, Hosni A, Chen E, Noonan AM, Koay EJ, Sinha R, Lock MI, Ohri N, Dorth JA, Delouya G, Swaminath A, Moughan J, Crane CH.
Dawson LA, et al. Among authors: krishnan s.
JAMA Oncol. 2024 Dec 19. doi: 10.1001/jamaoncol.2024.5403. Online ahead of print.
JAMA Oncol. 2024.
PMID: 39699905